Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Ajay K. Gopal; Brad S. Kahl; Christopher R. Flowers; Peter Martin; Stephen M. Ansell; Esteban Abella-Dominicis; Brian Koh; Wei Ye; Paul M. Barr; Gilles A. Salles; Jonathan W. Friedberg

doi:10.1182/blood-2016-12-757740

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Ajay K. Gopal, Brad S. Kahl, Christopher R. Flowers, Peter Martin, Stephen M. Ansell, Esteban Abella-Dominicis, Brian Koh, Wei Ye, Paul M. Barr, Gilles A. Salles, Jonathan W. Friedberg

Research output: Contribution to journal › Review article › peer-review

75 Scopus citations

Original language	English
Pages (from-to)	3037-3039
Number of pages	3
Journal	Blood
Volume	129
Issue number	22
DOIs	https://doi.org/10.1182/blood-2016-12-757740
State	Published - Jun 1 2017

Access to Document

10.1182/blood-2016-12-757740

Cite this

@article{f80d4520a9184ae68ecc7a2d373284fa,

title = "Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy",

author = "Gopal, {Ajay K.} and Kahl, {Brad S.} and Flowers, {Christopher R.} and Peter Martin and Ansell, {Stephen M.} and Esteban Abella-Dominicis and Brian Koh and Wei Ye and Barr, {Paul M.} and Salles, {Gilles A.} and Friedberg, {Jonathan W.}",

year = "2017",

month = jun,

day = "1",

doi = "10.1182/blood-2016-12-757740",

language = "English",

volume = "129",

pages = "3037--3039",

journal = "Blood",

issn = "0006-4971",

number = "22",

}

TY - JOUR

T1 - Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

AU - Gopal, Ajay K.

AU - Kahl, Brad S.

AU - Flowers, Christopher R.

AU - Martin, Peter

AU - Ansell, Stephen M.

AU - Abella-Dominicis, Esteban

AU - Koh, Brian

AU - Ye, Wei

AU - Barr, Paul M.

AU - Salles, Gilles A.

AU - Friedberg, Jonathan W.

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85020257653&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-12-757740

DO - 10.1182/blood-2016-12-757740

M3 - Review article

C2 - 28325864

AN - SCOPUS:85020257653

SN - 0006-4971

VL - 129

SP - 3037

EP - 3039

JO - Blood

JF - Blood

IS - 22

ER -

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Access to Document

Other files and links

Cite this